Effects of an angiotensin-converting enzyme inhibitor and a β-blocker on cerebral arterioles in rats

被引:51
|
作者
Chillon, JM
Baumbach, GL
机构
[1] Univ Iowa, Coll Med, Dept Pathol, Med Labs 100, Iowa City, IA 52242 USA
[2] Univ Iowa, Ctr Cardiovasc, Iowa City, IA 52242 USA
关键词
hypertension; chronic; vascular remodeling; angiotensin; hypertrophy; vascular;
D O I
10.1161/01.HYP.33.3.856
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
We examined the effects of an angiotensin-converting enzyme inhibitor, perindopril, and a beta-blocker, propranolol, on cerebral arterioles in stroke-prone spontaneously hypertensive rats (SHRSP). The structure and mechanics of cerebral arterioles were examined in untreated Wistar-Kyoto rats (WKY) and SHRSP that were untreated or treated for 3 months with a high (2 mg/kg per day) or a low (0.3 mg/kg per day) dose of perindopril or propranolol (250 mg/kg per day) alone or in combination with the low dose of perindopril. We measured pressure, external diameter, and cross-sectional area of the vessel wall (CSA) in maximally dilated (with EDTA) cerebral arterioles. Treatment of SHRSP with the high dose of perindopril or the combination of propranolol and the low dose of perindopril normalized cerebral arteriolar mean pressure (50+/-1 [mean+/-SEM] and 43+/-2 mm Hg vs 50+/-1 mm Hg in WKY and 94+/-3 mm Hg in untreated SHRSP; P<0.05), pulse pressure (15+/-1 and 16+/-1 mm Hg vs 13+/-1 mm Hg in WKY and 35+/-1 mm Hg in untreated SHRSP; P<0.05), and CSA (1103+/-53 and 1099+/-51 mu m(2), respectively, vs 1057+/-49 mu m(2) in WKY and 1281+/-67 mu m(2) in untreated SHRSP; P<0.05). In contrast, treatment of SHRSP with the law dose of perindopril or propranolol alone did not normalize arteriolar pulse pressure (24+/-1 and 21+/-1 mm Hg) and failed to prevent increases in CSA (1282+/-77 and 1267+/-93 mu m(2)). Treatment with either dose of perindopril or the combination of propranolol and perindopril significantly increased external diameter in cerebral arterioles of SHRSP (99+/-3, 103+/-2, and 98+/-3 mu m vs 87+/-2 mu m in untreated SHRSP; P<0.05), whereas propranolol alone did not (91+/-3 mu m; P>0.05). These findings suggest that effects of angiotensin-converting enzyme inhibitors on cerebral arteriolar hypertrophy in SHRSP map depend primarily on their effects on arterial pressure, particularly pulse pressure, whereas their effects on cerebral arteriolar remodeling (defined as a reduction in external diameter) may be pressure independent.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 50 条
  • [1] Effects of an angiotensin-converting enzyme inhibitor and a β-blocker on cerebral arteriolar dilatation in hypertensive rats
    Chillon, JM
    Baumbach, GL
    HYPERTENSION, 2001, 37 (06) : 1388 - 1393
  • [2] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [3] Effects of an angiotensin converting enzyme inhibitor on remodeling of cerebral arterioles.
    Chillon, JM
    Baumbach, GL
    FASEB JOURNAL, 1997, 11 (03): : 1258 - 1258
  • [4] Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat
    Dupuis, Francois
    Vincent, Jean-Martin
    Liminana, Patrick
    Chillon, Jean-Marc
    Capdeville-Atkinson, Christine
    Atkinson, Jeffrey
    JOURNAL OF HYPERTENSION, 2010, 28 (07) : 1566 - 1573
  • [5] ANTIPROTEINURIC AND RENOPROTECTIVE EFFECTS OF COMBINATION THERAPY WITH AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND AN ANGIOTENSIN RECEPTOR BLOCKER
    Sadiku, Edita
    Idrizi, Alma
    Gjata, Margarita
    Barbullushi, Myftar
    Hoti, Klit
    Tase, Mihal
    Koroshi, Alketa
    NEPHROLOGY, 2005, 10 : A136 - A136
  • [6] Paradoxical pressor response with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Sabitha, P.
    Adhikari, Prabha M.
    AUSTRALASIAN MEDICAL JOURNAL, 2011, 4 (07): : 364 - +
  • [7] Effects of angiotensin-converting enzyme inhibitor, angiotensin II type I receptor blocker and their combination on postinfarcted ventricular remodeling in rats
    Zhang, RY
    Wang, LF
    Zhang, L
    Meng, XN
    Li, SJ
    Wang, WR
    CHINESE MEDICAL JOURNAL, 2006, 119 (08) : 649 - 655
  • [8] Effects of genistein on angiotensin-converting enzyme in rats
    Xu, Yin-Yan
    Yang, Cui
    Li, Sheng-Nan
    LIFE SCIENCES, 2006, 79 (09) : 828 - 837
  • [9] Bradykinin mediates the acute effect of an angiotensin-converting enzyme inhibitor on cerebral autoregulation in rats
    Takada, J
    Ibayashi, S
    Nagao, T
    Ooboshi, H
    Kitazono, T
    Fujishima, M
    STROKE, 2001, 32 (05) : 1216 - 1219
  • [10] Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotection
    Hou, Fan Fan
    Zhou, Qiu Gen
    NEPHROLOGY, 2010, 15 : 57 - 60